 |
인쇄하기
취소
|
Binex , Abdi Ibrahim sign deal to sell Remicade biosimiar
Published: 2012-09-24 06:57:00
Updated: 2012-09-24 06:57:00
Binex Pharmaceuticals Co. said Thursday it established a strategic partnership with Abdi Ibrahim Pharmaceuticals to sell its Remicade biosimilar product in Turkey. Remicade is a globally renowned medication for rheumatoid arthritis.
Binex and Abdi Ibrahim will get the approval for sales and handle marketing in Turkey under the partnership.
The deal with Abdi Ibrahim is expected to help en...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.